| 期刊論文| 1. | Iizuka, T.(2012)。Physician Agency and Adoption of Generic Pharmaceuticals。American Economic Review，102(6)，2826-2858。   | | 2. | Hsieh, C. R.、Liu, Y. M.、Chang, C. L.(2013)。Endogenous technological change in medicine and its impact on health care costs: evidence from the pharmaceutical market in Taiwan。Eur J Health Econ，14，287-295。 | | 3. | Iizuka, T.(2007)。Experts' agency problems: evidence from the prescription drug market in Japan。Rand J Econ，38，844-862。 | | 4. | Iizuka, T.、Kubo, K.(2011)。The generic drug market in Japan: will it finally take off?。Health Econ Policy Law，6，369-389。 | | 5. | Liu, Y. M.、Kao Yang, Y. H.、Hsieh, C. R.(2012)。Regulation and competition in the Taiwanese pharmaceutical market under national health insurance。Journal of Health Economics，31(3)，471-483。 | | 6. | Ellison, S. F.、Snyder, C. M.(2010)。Countervailing power in wholesale pharmaceuticals。J Ind Econ，58，32-53。 | | 7. | Liu, Y. M.(2020)。Understanding profit margins of medical providers from prescription drugs: evidence from Taiwan。Int Health，12(4)，272-280。 | | 8. | Liu, Y. M.、Hsieh, C. R.(2014)。Profit-seeking behavior of medical providers and generic competition in the pharmaceutical market: evidence from Taiwan。B E J Econ Anal Pol，14，241-275。 | | 9. | Hsieh, C. R.、Sloan, F. A.(2008)。Adoption of pharmaceutical innovation and the growth of drug expenditure in Taiwan: is it cost effective?。Value Health，11，334-344。 | | 10. | 譚令蒂、洪乙禎、謝啟瑞(20071200)。論藥價差。經濟論文叢刊，35(4)，451-476。 延伸查詢 | | 11. | Liu, Y. M.、Kao, Y. H.、Hsieh, C. R.(2009)。Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan。J Health Econ，28，341-349。 | 研究報告| 1. | 劉亞明(2006)。醫院市場結構與藥品廠牌選擇之關係。臺北：科技部。 延伸查詢 | 圖書| 1. | Galbraith, John Kenneth(1952)。American capitalism: The concept of countervailing power。Boston：Houghton Mifflin。 | 其他| 1. | 監察院(2011)。「我國全民健康保險總體檢」調查報告，台北市：監察院。 延伸查詢 | 圖書論文| 1. | 黃文鴻(2019)。難以面對的「健保藥價差」情緒。健康保險。臺北：文華圖書館管理。 延伸查詢 | | 2. | Iizuka, T.(2009)。The economics of pharmaceutical pricing and physician prescribing in Japan。Prescribing Cultures and Pharmaceutical Policy in the Asia Pacific。Stanford, CA：Shorenstein Asia-Pacific Research Center。 | | 3. | Danzon, P. M.(2011)。The economics of the biopharmaceutical industry。The Oxford Handbook of Health Economics。New York, NY：Oxford University Press。 | |